Page last updated: 2024-11-06

decyl glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

decyl glucoside: a non-ionic surfactant used in rinse-off products [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3033856
SCHEMBL ID43196
MeSH IDM0491032

Synonyms (24)

Synonym
c16h32o6
decyl glucoside
(3r,4s,5s,6r)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol
d-glucopyranoside, decyl
decyl d-glucoside
decyl d-glucopyranoside
54549-25-6
einecs 259-218-1
(3r,4s,5s,6r)-2-(decyloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
AKOS016004985
68515-73-1
SCHEMBL43196
141464-42-8
W-203522
W-111093
mfcd23103077
decyl glucopyranoside
JDRSMPFHFNXQRB-IWQYDBTJSA-N
DS-3841
DTXSID30893008
n-decyl-d-glucopyranoside
(3r,4s,5s,6r)-2-(decyloxy)-6-(hydroxymethyl)-tetrahydro-2h-pyran-3,4,5-triol
A867031
(3r,4s,5s,6r)-2-(decyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The Cosmetic Ingredient Review (CIR) Expert Panel assessed the safety of 19 alkyl glucosides as used in cosmetics and concluded that these ingredients are safe in the present practices of use and concentration when formulated to be nonirritating."( Safety assessment of decyl glucoside and other alkyl glucosides as used in cosmetics.
Andersen, FA; Belsito, DV; Bergfeld, WF; Fiume, MM; Heldreth, B; Hill, RA; Klaassen, CD; Liebler, D; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (28.57)29.6817
2010's8 (57.14)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (15.00%)6.00%
Case Studies7 (35.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]